Significant Improvement in AI Investment Returns Enhances Earnings Prospects, Bullish Logic for Blue-Chip UnitedHealth Is Reshaping Jul 3, 2026 Life Science
Pharmaceutical Giant AbbVie Makes a Major Bet on a New Immunotherapy, and Its Dividend Growth Record Attracts Income-Focused Investors Jul 1, 2026 Life Science
Anthropic Launches Claude Science to Enter Life Sciences, AI Drug Discovery Stocks Tumble in Response Jun 30, 2026 Life Science
Insiders Sell Nearly $900,000 in Stock as Monterosa Medical Faces Key Clinical Data Test Jun 29, 2026 Life Science
Innovative Pipeline Supports Long-Term Value, Moderna Still Has Upside After Doubling in Price Jun 26, 2026 Life Science
Impressive Clinical Trial Data Drives Intellia Therapeutics Up 70% This Year Jun 25, 2026 Life Science
Mid-Cap Biotech Viking Therapeutics Could Emerge as a Potential Challenger to Eli Lilly and Novo Nordisk Jun 23, 2026 Life Science
Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee Jun 22, 2026 Life Science
AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths Jun 19, 2026 Life Science, Technology
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy Jun 18, 2026 Life Science
